000050 Research Article Veränderung der formalinbedingten c-fos-ähnlichen Immunreaktivität im Rückenmark infolge Stress und Behandlung mit Morphin und Ketoamin Asma Hayati Asma Hayati Ahmad A

Department of Physiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

asmahayatiahmad@yahoo.co.uk author Zalina Zalina Ismail I

School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

zalina@kb.usm.my author Myo Myo Than T

Department of Anatomy, Perak College of Medicine, Ipoh, Perak, Malaysia

myothan@hotmail.com author Che Badariah Che Badariah Abdul Aziz AA

Department of Physiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, MalaysiaDepartment of Physiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

badariah@kb.usm.my author Azhar Azhar Ahmad A

Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

aazhar@kck.usm.my author Idris Idris Long L

School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

idris_usm@yahoo.com author German Medical Science GMS Publishing House

Düsseldorf

RATS ANIMALS RATS, SPRAGUE-DAWLEY metabolism STRESS, PSYCHOLOGICAL metabolism PROTO-ONCOGENE PROTEINS C-FOS biosynthesis drug effects FORMALDEHYDE pharmacology MORPHINE pharmacology KETAMINE pharmacology ANALGESIA psychology PAIN metabolism COMPARATIVE STUDY 610 Fos stress pain formalin morphine ketamine c-fos Stress Schmerz Formalin Morphin Ketoamin 20080121 20080527 20080630 engl 1612-3174 6 GMS German Medical Science GMS Ger Med Sci 05 Die Induktion von c-fos-Aktivität im Rückenmark unter Schmerz ist allgemein bekannt. Diese Studie hat zum Ziel, die Wirkung von Schwimmstress auf die durch Formalininjektion ausgelöste c-fos-ähnliche Immunreaktivität und wie diese unter Ketoamin- und Morphinbehandlung verändert wird zu untersuchen. Akut gestresste und nicht-gestresste, ausgewachsene, männliche Sprague-Dawley-Ratten wurden mit intraperitonealen Injektionen von Ketoamin (5 mg/kg) oder Morphin (10 mg/kg) oder durch Injektionen von physiologischer Kochsalzlösung 5 Minuten vor Beginn des Experimentes behandelt. Die akute Stresssituation wurde durch Schwimmen im Wasser bei 20°C über 3 Minuten erzeugt. Verdünntes Formalin (Formaldehyd, Merck) wurde in die hintere Pfote der Ratten injiziert und der Formalineffekt untersucht. Die Ratten wurden anschließend getötet, das Rückenmark (L4-L5) wurde für die immunhistologischen Analysen der c-fos-ähnlichen Immunreaktivität herauspräpariert. Die Auswertung in der zweifaktoriellen Varianzanalyse zeigte im Formalintest signifikante Effekte von Stress, von Pharmaka und von Stress-Pharmaka-Interaktionen auf die c-fos-ähnliche Immunreaktivität. Sowohl Morphin als auch Ketoamin erzeugten eine Analgesie im Formalintest. In der mit physiologischer Kochsalzlösung behandelten gestressten Gruppe war die c-fos-ähnliche Immunreaktivität verglichen mit den nicht-gestressten kochsalzbehandelten Tieren auf der ipsilateralen Seite unterdrückt (p<0,01), aber auf der contralateralen Seite (p<0,01) erhöht. Bei Morphin (ipsilateral p<0,05; contralateral p<0,001) und bei Ketoamin (ipsilateral p<0,05; contralateral p<0,05) war sie verglichen mit ihren korrespondierenden nicht gestressten Gruppen sowohl auf der ipsilateralen als auch auf der contralateralen Seite erhöht. Aus den Experimenten folgt, dass Stress zu diskrepanten Ergebnissen zwischen verhaltensbedingten Manifestationen von Schmerz und c-fos-Induktion im Rückenmark führen kann. Induction of c-fos in the spinal cord due to pain is well established. This study aims to look at the effects of acute swim stress on Fos-like immunoreactivity (FLI) induced by formalin and how it is modulated by ketamine and morphine. Acutely-stressed and non-stressed adult male Sprague Dawley rats were pretreated with intraperitoneal injection of ketamine 5 mg/kg (Ketava, Atlantic Lab), morphine 10 mg/kg (Rhotard, Custom Pharmaceutical), or saline, 5 minutes prior to experimentation. Rats were acutely stressed by swimming for 3 min in 20°C water. Dilute formalin (Formaldehyde, Merck) was injected to the hindpaw and the formalin score recorded. Rats were then sacrificed and spinal cords (L4-L5) removed for immunohistochemical analysis of FLI. Two-way ANOVA showed significant effects of stress, drug and stress-drug interactions in formalin test and FLI. Both morphine and ketamine produced analgesia in the formalin test. In the saline stressed group, FLI was suppressed on the ipsilateral side (p<0.01) but increased on the contralateral side (p<0.01) compared with non-stressed saline. In morphine and ketamine stressed groups, FLI was increased on both ipsilateral and contralateral sides for morphine (ipsilateral: p<0.05; contralateral: p<0.001) and ketamine (ipsilateral: p<0.05, contralateral: p<0.05) compared with their corresponding non-stressed groups. In conclusion, presence of stress may lead to discrepancy between behavioural manifestation of pain and c-fos induction in the spinal cord. Introduction The discovery of the c-fos proto-oncogene led to extensive studies on pain-induced Fos-like immunoreactivity (FLI) expression in the central nervous system including the spinal cord , , , trigeminal brain stem neurones , supraoptic nucleus of the hypothalamus and thalamus . C-fos has been designated the marker for noxious stimulation and implicated in the development of central sensitization mediated by the N-Methyl-D-Aspartate (NMDA) receptor . Endogenous opioids, on the other hand, are released under stressful conditions and produce analgesia by inhibiting the excitability of sensory nerves and/or the release of excitatory neurotransmitters that leads to modulation of pain and induction of analgesia . These form the basis for utilizing morphine, an opiate, and/or ketamine, an NMDA receptor antagonist, in preemptive analgesia , . C-fos has been utilized as a marker to evaluate the efficacy of analgesic and anaesthetic drugs in preventing the “memory of pain” , . However, the effects of ketamine on c-fos induction , and its usage as preemptive analgesic agent produced conflicting results , , , . Some reported beneficial effects while others did not obtain supportive results . While c-fos expression is clearly the result of noxious stimulation, the question arises as to whether its induction can be modified by other factors such as stress accompanying the pain stimulus. Various stressors such as footshock , swimming and restraint are capable of producing analgesia in laboratory animals. This phenomenon is called stress-induced analgesia that can be opioid and/or non-opioid mediated . Studies have demonstrated that c-fos expression was induced by stress in certain areas of the brain and in peripheral organs . However, very few studies have looked at stress induced expression of c-fos in the spinal cord and how pain modulates its expression. The spinal cord plays a major role in the integration and modulation of nociceptive inputs prior to messages being sent to higher centres . Harris et al. demonstrated that rats preexposed to conditioned stimuli paired with an aversive event exhibited reduced pain behaviour in the formalin test that corresponded with reduction in Fos expression in the spinal cord. These conditioned hypoalgesic responses are mediated by descending pathways from the midbrain and brainstem that disrupt nociceptive processing in the spinal cord. The aim of the present study was to determine the effects of acute swim stress on Fos-like immunoreactivity in the rat due to formalin injection and how ketamine and morphine modulate its expression. Materials and methods Animals Experiments were performed on adult male Sprague-Dawley rats weighing between 230–350 g. The rats were maintained in a 12-h light dark cycle and allowed free access to food and water. They were housed in individual cages and allowed adaptation for at least four days in the physiology department laboratory. Each animal was used only once. Experiments were performed between 08:00 and 16:00 in the physiology department laboratory. Animals were obtained from Animal House, Health Campus, Universiti Sains Malaysia. This study was approved by the Animal Ethics Committee of Universiti Sains Malaysia. Drugs used All drugs and saline controls were administered as pretreatment i.e. before the swim stress and formalin injection procedures. Saline 0.9% was used as vehicle to dissolve the drugs. The drugs used were ketamine 5 mg/kg, morphine 10 mg/kg, and saline 0.9% as control. All drugs and saline were injected intraperitoneally at a volume of 1 ml/kg. As the ketamine dose used was low, the rats experienced minimal duration (less than five minutes) of loss of righting reflex and had recovered fully before undergoing swim stress. The morphine dose used was shown to produce analgesia in the rat formalin test . Experimental groups Rats were allocated to one of six experimental groups with eight animals in each group. The non-stressed groups were pretreated with ketamine, morphine, or saline, and formalin injection was administered 30 minutes after. The stressed groups received similar pretreatment as the non-stressed groups. However, 17 minutes after pretreatment, they were subjected to three minutes of swim stress in 20ºC water followed by formalin injection 10 minutes after cessation of swimming. Ten minutes was chosen as it corresponded to the time of peak antinociception following swim stress . Acute swim stress procedure A container measuring 92 cm x 46 cm x 46 cm high containing 20 cm of water at 20°C was used for this purpose. Rats were placed in the water individually and left to swim for three minutes before being removed , . Formalin injection Ten minutes after cessation of acute swim-stress, the rats were manually restrained by a second experimenter and 50 μl of dilute (1%) formalin was injected to the plantar aspect of its right hindpaw. The rat was then placed in a perspex testing chamber measuring 26 cm x 20 cm x 20 cm. A mirror was placed below the floor of the chamber at 45° angle to allow an unobstructed view of the rat’s paws , , . The amount of time spent in each of four behavioural categories, 0–3, was recorded with a videocam starting from the time of injection until the end of one hour. The tape was later viewed by two observers blinded to the treatment of each rat and the formalin test score was tabulated every minute and averaged at 5-minute intervals . The quantification was based on the total time spent in 4 behavioural categories . The categories were: 0 = the injected paw is not favoured (i.e. foot flat on the floor with toes splayed) indicating insignificant or no pain felt 1 = the injected paw has little or no weight on it with no toe splaying indicating mild pain felt 2 = the injected paw is elevated and the heel is not in contact with any surface indicating moderate pain 3 = the injected paw is licked, bitten or shaken indicating severe pain All rats were used only once and sacrificed after experiment. Sacrifice of animals and perfusion-fixation of spinal cord Five rats from each group were selected for immunohistochemistry to detect Fos-like immunoreactivity (FLI). All rats were sacrificed 120 minutes after formalin injection to ensure that the pattern of Fos expression was contributed by the entire second phase of the formalin test . Rats were anaesthetized deeply with an overdose of sodium pentobarbitone intraperitoneally . Following the loss of pinch reflex, thoracotomy was done to expose the heart and an 18G branula was inserted into the apex of the left ventricle. An outlet for the perfusion solution to flow out was created by making a snip over the right atrium. Perfusion was then performed by gravity method using first phosphate-buffered saline (PBS) until clear fluid was flushed out (approximately 120 ml). This was followed by 500 ml of cold 4% paraformaldehyde in phosphate buffer (PB) 0.1 mol litre-1 (pH=7.4) . Dissection of spinal cord and cryostat sectioning Rats were dissected by posterior approach and vertebrae were exposed. The sciatic nerve was identified and traced from the popliteal fossa to its origins at L4 and L5 segments of the spinal cord . Laminectomy was done to expose the spinal cord and the L4 and L5 segments were removed. Extracted spinal cords were labeled with a 1-mm lateral, longitudinal incision contralateral to the side of formalin injection . The cut segments were then post-fixed in fresh perfusion solution (4% PFA in PB 0.1M) at 4°C for 4 hours, and cryoprotected overnight in 20% sucrose in phosphate buffer 0.1M at 4°C until the cord sank . The segments were next embedded in tissue freezing medium (Jung) and sliced into 30 µm sections using a cryostat . Sections were transferred using a paintbrush to a 24-well multiwell plate containing 500 µl of PBS in each well. Immunohistochemistry Sections were stained with a three-step peroxidase avidin-biotin complex (ABC) method (purified primary antibody, biotinylated secondary antibody, and ABC with DAB (diaminobenzidine)) for immunohistochemical localization of Fos protein . After rinsing twice with Tris-buffered saline (TBS) at 5 minutes each, the sections were incubated with primary rabbit polyclonal anti-Fos antiserum directed against residues 4–17 of the N-terminal region of Fos peptide (Ab-5, Oncogene) diluted 1:20,000 with TBS containing 2% normal goat serum (NGS) and 0.2% Triton X-100 for 48 hours at 4°C with constant gentle agitation . After rinsing with three changes of Tris-Triton at 10 minutes each, the sections were incubated with biotinylated secondary antibody (goat anti-rabbit antiserum; Vectastain, Vector Laboratories) diluted 1:200 in TBS containing 2% normal goat serum (NGS) and 0.2% Triton X-100 for 1 hour at room temperature. Sections were then rinsed with three changes of Tris-Triton at 10 minutes each, and then reacted with an avidin-biotin complex (Elite ABC, Vectastain) diluted 1:50 in TBS for 1 hour at room temperature. They were then rinsed in Tris-Triton at three times 10 minutes and reacted with diaminobenzidine solution (0.5 mg per ml of TBS) for 10 minutes . 0.2% hydrogen peroxide (H2O2) was added to each well and a brown discolouration was observed after 15 minutes. The reaction was stopped by rinsing the sections with three changes of TBS at 10 minutes each. After a quick rinse in deionized water, all sections were then mounted on gelatin-subbed slides and air-dried overnight. Slides were then dehydrated with absolute ethanol for 15 minutes, mounted with Styrolyte Mounting Medium and protected with a coverslip . To examine the specificity of the primary antibody, non-specific staining was tested by omitting one of each step simultaneously for the non-stressed saline control rats. Incubation without anti-c-fos antibody, secondary antibody, ABC and DAB was performed on different sections and dark staining of the nucleus was completely absent . This approach ensured high quality of specificity for the antibody in use. Counting of FLI-labeled neurons Sections were examined using light microscopy attached to an image analyzer (Leica QWin) and the segmental level was determined according to the grey matter landmarks as described by Molander et al. . Immunohistochemically detected nuclear-associated reaction product was referred to as Fos-like immunoreactivity (FLI) . At least 8–12 of the L4/L5 sections were scanned for each rat, and six sections with the greatest number of Fos positive cells, characterized by dark brown staining distinguishable from background , were selected. Images of the spinal cord sections were captured at X25 to determine the lamina distribution and at X50 to localize Fos positive cells. Saved images were then printed out in colour on glossy photo paper. The grey matter of each section was divided further into 4 regions according to Molander et al. : the superficial dorsal horn (laminae I–II) the nucleus proprius (laminae III–IV) the neck of the dorsal horn (laminae V–VI) the ventral gray (laminae VII–X) Fos positive cells were counted from the printed images with respect to each lamina by a blinded investigator and counterchecked with the image analyzer once to ensure that the correct dots were counted. The counts were then averaged for each rat. Counts that were questionable in either quantity or quality were excluded. Statistical analysis Pain behaviour scores by formalin test were analyzed using two-way analysis of variance (ANOVA) with repeated measures with one within subjects factor (time) and two between subjects factors (stress and drug). Two-way ANOVA</PlainText></TextGroup> was used to analyze the effects of phase 1 formalin test (mean score at 5 minutes) and phase 2 (mean of scores from 10 to 60 minutes) with stress (non stress vs. stress) and drug (saline vs. morphine vs. ketamine) as the main factors. Post hoc Tukey test was performed for drug and significance was accepted at p&#60;0.05.</Pgraph> <Pgraph>For each spinal cord section analyzed, the different laminae were divided into superficial lamina (laminae I&#8211;II), the nucleus proprius (laminae III&#8211;IV), the neck of the dorsal horn (laminae V&#8211;VI), and the ventral lamina (laminae VII&#8211;X). FLI expression was counted according to the lamina. Data were analyzed using two-way ANOVA by SPSS 11.0, with stress (non stress vs. stress) and drug (saline vs. morphine vs. ketamine) as the main factors. One-way ANOVA was used to compare the FLI between the ipsilateral (injected) and contralateral (non-injected) side of the spinal cord for each group and between the non-stressed and stressed groups for each treatment. Post hoc Tukey test was performed for the three drug groups. Data were expressed as mean &#177; SEM (standard error of mean) and statistical significance was taken when p&#60;0.05.</Pgraph> </TextBlock> <TextBlock linked="yes" name="Results"> <MainHeadline>Results</MainHeadline> <SubHeadline>Formalin test </SubHeadline> <Pgraph>Analysis using two-way ANOVA with repeated measures revealed significant within subjects (time, time x stress, time x drug, time x stress x drug: all p&#60;0.001) and between subjects effects of stress (F<Subscript>(1,42)</Subscript>&#61;23.82, p&#60;0.001), drug (F<Subscript>(2,42)</Subscript>&#61;50.52, p&#60;0.001) and stress-drug interaction (F<Subscript>(2,42)</Subscript>&#61;7.31, p&#60;0.05). Post hoc Tukey test showed significant difference between both morphine and ketamine groups compared to saline (morphine vs. saline: p&#60;0.001; ketamine vs. saline: p&#60;0.001). There was no significant difference between morphine and ketamine.</Pgraph> <Pgraph>In the non-stressed groups, formalin produced the typical biphasic pain response in the saline group (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). The first phase includes a burst of activity within 30 seconds of formalin injection. This phase lasted for about 5 minutes and was followed by a 5 to 10 minutes of reduced response i.e. the rats showed very little nociceptive behaviour, and then by a second phase of activity that lasts for at least 60 minutes after the formalin injection. For both morphine and ketamine groups, the biphasic response was markedly attenuated compared to the saline group signifying analgesia. This attenuation is marked at 10 minutes until 35 minutes post-formalin injection, after which the formalin scores for both treatment groups started to increase. </Pgraph> <Pgraph>For the stressed groups, morphine and saline groups showed biphasic pattern but the second phase of the formalin test was depressed (Figure 2 <ImgLink imgNo="2" imgType="figure"/>). While for the ketamine group, the second phase was completely suppressed, obliterating the biphasic pattern. At 5 minutes post-formalin, which is equivalent to phase 1, ketamine demonstrated the lowest score which was significantly (p&#60;0.05) lower than saline. After 5 minutes, however, all three groups showed marked attenuation of the formalin score. For saline this attenuation lasted until 35 minutes post-formalin when the score started to steadily increase again. Morphine showed slight increase in the score after 35 minutes but the scores were still significantly (p&#60;0.01) lower than the saline group. Ketamine, however, demonstrated the greatest analgesia by complete attenuation of the formalin score until 60 minutes post-formalin.</Pgraph> <SubHeadline>Formalin test results during phase 1 and phase 2</SubHeadline> <Pgraph>Comparing both the non-stressed and the stressed groups during phase 1 (5 minutes post-formalin injection) by two-way ANOVA with stress and drug as main factors, there was significant effects of drug (F<Subscript>(2,42)</Subscript>&#61;7.61, p&#60;0.05) and stress-drug interaction (F<Subscript>(2,42)</Subscript>&#61;3.78, p&#60;0.05) on the formalin score. No significant effect of stress was seen during this phase. Post hoc Tukey test for drug showed significant reduction of formalin score for ketamine compared to saline (p&#60;0.05). </Pgraph> <Pgraph>During phase 2, significant effects of stress (F<Subscript>(1,42)</Subscript>&#61;27.37, p&#60;0.001), drug (F<Subscript>(2,42)</Subscript>&#61;57.03, p&#60;0.001) and stress-drug interaction (F<Subscript>(2,42)</Subscript>&#61;5.22, p&#60;0.05) on the formalin score were seen. Post hoc analysis showed significant reduction in the formalin test scores in the two treatment group morphine and ketamine compared to saline. There was no significant difference between morphine and ketamine. </Pgraph> <SubHeadline>Summary of formalin test results</SubHeadline> <Pgraph>These results show that in the non-stressed groups, both morphine 10 mg&#47;kg and ketamine 5 mg&#47;kg produced analgesia in the formalin test. All three stressed groups demonstrated stress-induced analgesia during phase 2. This analgesia was enhanced by prior treatment with morphine or ketamine. </Pgraph> <SubHeadline>FLI</SubHeadline> <Pgraph>In the non-stressed animals given formalin, the highest density of FLI expression can be seen in the saline group, concentrated mainly on the ipsilateral side. In the morphine and ketamine groups, there were reductions in FLI expression (Figure 3 <ImgLink imgNo="3" imgType="figure"/>). </Pgraph> <Pgraph>All stressed groups showed FLI expression on both the ipsilateral and contralateral sides. However, the distribution of the FLI in ipsilateral laminae I&#8211;II was more scattered compared with the non-stressed groups which concentrated mainly over the medial aspect of the laminae. Among the three groups, ketamine stressed group demonstrated the highest FLI expression on both the ipsilateral and contralateral sides of the spinal cord (Figure 4 <ImgLink imgNo="4" imgType="figure"/>).</Pgraph> <SubHeadline>Ipsilateral side</SubHeadline> <Pgraph>On the ipsilateral side, analysis by two-way ANOVA revealed significant effects of stress in all laminae. There were also significant effects of drug and stress-drug interaction in laminae I&#8211;II, III&#8211;IV and V&#8211;VI (Table 1 <ImgLink imgNo="1" imgType="table"/>). One-way ANOVA with post hoc Tukey test for the drug groups showed that in the non stressed groups, both morphine and ketamine had significantly lower density of FLI on the ipsilateral side (morphine: laminae I&#8211;II and laminae V&#8211;VI, p&#60;0.001; ketamine: laminae I&#8211;II, p&#60;0.001 and laminae V&#8211;VI, p&#60;0.05) compared to saline. Presence of stress caused a significant reduction in FLI expression in the saline group (laminae I&#8211;II and laminae V&#8211;VI, p&#60;0.01) compared with saline non-stressed. In morphine and ketamine groups, however, stress caused increases in FLI expression compared with their respective non stressed groups (morphine: laminae I&#8211;II, III&#8211;IV and V&#8211;VI: p&#60;0.001; laminae VII&#8211;X: p&#60;0.01 compared with morphine non stressed; ketamine: laminae I&#8211;II, p&#60;0.001; laminae III&#8211;IV, p&#60;0.05; laminae V&#8211;VI, p&#60;0.05 compared with ketamine non stressed). Comparing all stressed groups, ketamine stressed group showed a significantly higher FLI expression compared to the saline stressed group (laminae I&#8211;II, p&#60;0.001; laminae III&#8211;IV, p&#60;0.05; laminae V&#8211;VI, p&#60;0.01) and morphine stressed group (laminae I&#8211;II, p&#60;0.001; laminae V&#8211;VI, p&#60;0.05) (Figure 5 <ImgLink imgNo="5" imgType="figure"/>).</Pgraph> <SubHeadline>Contralateral side</SubHeadline> <Pgraph>On the contralateral side, analysis by two-way ANOVA revealed significant effects of both stress and drug factors in laminae I&#8211;II, III&#8211;IV and V&#8211;VI, and stress-drug interaction in laminae I&#8211;II and V&#8211;VI (Table 2 <ImgLink imgNo="2" imgType="table"/>). One-way ANOVA with post hoc Tukey test showed that in the non-stressed groups, no significant differences were seen among the three groups. Saline stressed group had a significantly higher FLI expression in laminae I&#8211;II (p&#60;0.01) and laminae V&#8211;VI (p&#60;0.001) compared to saline non-stressed group. Morphine stressed group demonstrated significantly higher FLI expression in all laminae but is most marked in laminae III&#8211;IV and laminae V&#8211;VI (p&#60;0.001) compared to morphine non-stressed group. Ketamine stressed group also showed a significantly higher FLI expression in laminae I&#8211;II (p&#60;0.001), laminae III&#8211;IV (p&#60;0.05) and laminae V&#8211;VI (p&#60;0.01) compared to ketamine non-stressed group. Comparing all stressed groups, the FLI expression was significantly higher in the ketamine stressed group compared to saline stressed group (laminae I&#8211;II, p&#60;0.01; laminae V&#8211;VI, p&#60;0.05) and morphine stressed group (laminae I&#8211;II, p&#60;0.001) (Figure 6 <ImgLink imgNo="6" imgType="figure"/>).</Pgraph> <Pgraph>From these results, it can be concluded that the significant interactions between stress and drug indicate that there is significant effect of stress but it is not the same in each drug. It also indicates that the effects of drugs are significant, but the drug effects are different between those with stress and those without stress.</Pgraph> <Pgraph></Pgraph> </TextBlock> <TextBlock linked="yes" name="Discussion"> <MainHeadline>Discussion</MainHeadline> <Pgraph>The biphasic response after formalin injection is due to direct chemical stimulation of nociceptors for phase 1 <TextLink reference="31"></TextLink>, and local inflammatory processes <TextLink reference="44"></TextLink> as well as processes in the spinal cord <TextLink reference="45"></TextLink> for phase 2. The finding that ketamine suppressed phase 2 but not phase 1 of the formalin test in this study is consistent with previous studies that used even higher doses of ketamine <TextLink reference="46"></TextLink>. Lee and Lee <TextLink reference="47"></TextLink> demonstrated suppression of both phases but the quantification of pain behaviour was only by counting the incidence of flinching. This study shows that a ketamine dose as low as 5 mg&#47;kg is antinociceptive in the rat formalin test as shown in previous studies <TextLink reference="37"></TextLink>, <TextLink reference="47"></TextLink>. Studies done with other NMDA antagonists such as dextromethorphan and memantin <TextLink reference="46"></TextLink> and MK-801 <TextLink reference="48"></TextLink> also showed similar pattern of phase 2 suppression. The fact that ketamine produced preemptive analgesia by preventing central sensitization during phase 1 as shown by Gilron et al. (37) is supported by clinical data suggesting preemptive analgesia with ketamine <TextLink reference="20"></TextLink>, <TextLink reference="49"></TextLink> and by electrophysiological study demonstrating inhibition of dorsal horn neuronal firing by ketamine after noxious stimulation <TextLink reference="50"></TextLink>.</Pgraph> <Pgraph>Following systemic administration of ketamine, several mechanisms have been proposed to be involved in producing the analgesia. The first one reflects actions of ketamine on mechanisms within the spinal cord involving central sensitization <TextLink reference="51"></TextLink>. Other mechanisms include supraspinal actions, either by inhibiting NMDA receptors at, for example, thalamic sites, or activation of descending pain inhibitory mechanisms involving biogenic amines <TextLink reference="52"></TextLink>. Active metabolites such as norketamine also contribute to systemic actions of ketamine <TextLink reference="53"></TextLink>. It has also been shown that antagonists of NMDA receptors modulate elevated discharge of spinal nociceptive dorsal horn neurons that manifests as suppression of phase 2 of the formalin test <TextLink reference="54"></TextLink>. Benrath et al. <TextLink reference="55"></TextLink>, in an <Mark2>in vivo</Mark2> experiment, demonstrated that low-dose S(&#43;)-ketamine does not affect C-fibre-evoked potentials alone but blocks long term potentiation induction in pain pathways. </Pgraph> <Pgraph>Swim stress, as expected, reduced formalin nociceptive response during the second phase. Previous studies using similar swim stress paradigm also produced similar result <TextLink reference="56"></TextLink>. The analgesia produced by this swim stress paradigm has been shown to be mediated by &#948;-opioid receptor <TextLink reference="56"></TextLink>. However another study by Vaccarino et al. <TextLink reference="33"></TextLink> showed that subjecting mice to the same swim-stress paradigm produced a non-opioid analgesia in the formalin test. This and another study <TextLink reference="23"></TextLink> demonstrated that another NMDA antagonist, MK-801 (dizocilpine maleate), blocked the analgesia produced by swim stress. This is in contrast with this study which showed enhancement of stress-induced analgesia by ketamine. However, Vaccarino et al. <TextLink reference="33"></TextLink> only measured formalin-induced nociceptive response during the initial 10 minutes following formalin injection i.e. equivalent to phase 1. Therefore, the NMDA mediation of the swim stress may be involved only during phase 1. However, in this study, ketamine inhibited the first phase after swim stress i.e. producing analgesia instead of blocking it so some other explanation may be likely for this discrepancy <TextLink reference="56"></TextLink>. The reason may be due to diminished NMDA-mediated neural transmission by swim stress <TextLink reference="57"></TextLink>. This study also demonstrated the additive effects of swim stress and the two treatment groups morphine and ketamine during phase 2. Post hoc analysis did not show significant difference between ketamine and morphine.</Pgraph> <Pgraph>Formalin injection induced FLI expression on the ipsilateral side of the spinal cord in the unstressed rats. Intraperitoneal administration of morphine and ketamine significantly reduced FLI expression on the ipsilateral side. These findings are consistent with earlier studies demonstrating that morphine <TextLink reference="58"></TextLink>, <TextLink reference="59"></TextLink> and ketamine <TextLink reference="40"></TextLink>, <TextLink reference="60"></TextLink> reduce FLI expression on the ipsilateral side of the spinal cord. This is consistent with the behavioural analgesia observed in the formalin test.</Pgraph> <Pgraph>Following acute swim stress, however, marked difference was observed in the effects of formalin injection on the FLI expression in the three groups. FLI expression was markedly reduced on the ipsilateral side of the formalin injection in the saline stressed group possibly through descending pain inhibitory system <TextLink reference="61"></TextLink>, and segmental pain modulation in the spinal cord <TextLink reference="62"></TextLink>, <TextLink reference="63"></TextLink>. On the contralateral side, however, FLI expression was increased. This indicates that for FLI to be induced on the contralateral side, both pain stimulus and stress have to be present. Bruijnzeel et al. <TextLink reference="64"></TextLink> and de Lange et al. <TextLink reference="65"></TextLink> demonstrated how a single stressful experience caused altered brain and brain stem responsivity as evidenced by increased c-<Mark2>fos</Mark2> expression although behavioural sensitization was not expressed. Crane et al. <TextLink reference="66"></TextLink> showed that restraint stress induced c-<Mark2>fos</Mark2> expression in the sympathetic preganglionic neurons of the thoracic spinal cord. All these findings suggest alterations in the neural pathways involved in the processing of stress and pain.</Pgraph> <Pgraph>For the experimental groups, both morphine and ketamine increased FLI expression on both sides of the spinal cord (laminae I&#8211;II and laminae V&#8211;VI). This again shows that in the presence of stress, the analgesia seen by behavioural assessment is not mirrored by the FLI expression which is indicative of neuroplastic changes in the pain pathway. While the behavioural component of pain was suppressed, the c-<Mark2>fos</Mark2> proto-oncogene continued to be expressed. Moreover, stress and morphine or ketamine increased the induction of FLI expression, suggesting synergistic action of stress and either of the two drugs on FLI induction. This indicates that in the presence of acute swim stress, both morphine and ketamine fail to prevent spinal sensitization despite inhibition of behavioural manifestation of pain. The discrepancy between behavioural responses and FLI could be contributed by the potential analgesic effects of ketamine unrelated to NMDA receptor antagonism <TextLink reference="67"></TextLink>, or induction of FLI by ketamine via the &#963; receptors <TextLink reference="43"></TextLink>. This discordance between pain behaviour and spinal FLI was also shown by Gilron et al. <TextLink reference="37"></TextLink>. The increase in FLI expression in the swim stress groups could also be due to neuronal activation of both excitatory and inhibitory neurons activated by noxious stimulation and stress-induced modulatory pathways respectively <TextLink reference="68"></TextLink>. However, in this study, receptor-labelling was not done to determine the neurons that expressed FLI. Of more concern is whether the neuronal activation can lead to long-term detrimental changes in the central nervous system. This study used only one indicative factor (FLI) and cannot be used to conclude for overall neuronal activity since each visualization parameter such as FosB, FRA, or Jun proteins has its own characteristics of expression <TextLink reference="69"></TextLink>. Also, most neuronal activity might not be linked with induction of transcription factors. Alternative approaches to monitor neuronal activity should be employed such as examination of signal transduction intermediates, transcriptional&#47;translational intermediates, and receptor translocation <TextLink reference="70"></TextLink>.</Pgraph> <Pgraph>In clinical situations, the fact that ketamine pretreatment produces conflicting results suggests the presence of confounding effects of stress either in the form of operative, psychological, or other forms of stress. However, further research is required before this parallelism between clinical and animal studies can be made. At this point, it can be suggested that pain assessment based on what is felt by the patient, such as the Visual Analogue Scale (VAS), does not necessarily mirror the plasticity changes taking place in the spinal cord. Similarly, this study shows that although c-<Mark2>fos</Mark2> is often considered as a marker for neuroplasticity changes in the spinal cord, it may not necessarily reflect the only changes in neuroplasticity that occur in relation to pre-emptive analgesia. Stress is a major factor that must be considered in acute pain management in order to prevent c-<Mark2>fos</Mark2> expression and neuroplastic modification of the pain pathway <TextLink reference="71"></TextLink>. Findings from the present study suggest that stress together with pain can enhance neuroplasticity changes.</Pgraph> <Pgraph>In conclusion, these investigators report significant increase in FLI expression in the spinal cord in association with stress and pretreatment with ketamine&#47;morphine in the formalin pain model. This study suggests that equal emphasis has to be placed on the management of both pain and stress as neuroplasticity may lead to long-term changes in the central nervous system.</Pgraph> </TextBlock> <TextBlock linked="yes" name="Notes"> <MainHeadline>Notes</MainHeadline> <SubHeadline>Conflicts of interest</SubHeadline> <Pgraph>None declared.</Pgraph> <SubHeadline>Acknowledgement</SubHeadline> <Pgraph>This study was made possible by the USM short term grant.</Pgraph> </TextBlock> <References linked="yes"> <Reference refNo="1"> <RefAuthor>Curran T</RefAuthor> <RefAuthor>Teich NM</RefAuthor> <RefTitle>Identification of a 39,000-dalton protein in cells transformed by the FBJ murine osteosarcoma virus</RefTitle> <RefYear>1982</RefYear> <RefJournal>Virology</RefJournal> <RefPage>221-35</RefPage> <RefTotal>Curran T, Teich NM. Identification of a 39,000-dalton protein in cells transformed by the FBJ murine osteosarcoma virus. Virology. 1982;116(1):221-35.</RefTotal> </Reference> <Reference refNo="2"> <RefAuthor>Hunt SP</RefAuthor> <RefAuthor>Pini A</RefAuthor> <RefAuthor>Evan G</RefAuthor> <RefTitle>Induction of c-fos-like protein in spinal cord neurons following sensory stimulation</RefTitle> <RefYear>1987</RefYear> <RefJournal>Nature</RefJournal> <RefPage>632-4</RefPage> <RefTotal>Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 1987;328(6131):632-4.</RefTotal> </Reference> <Reference refNo="3"> <RefAuthor>Abbadie C</RefAuthor> <RefAuthor>Taylor BK</RefAuthor> <RefAuthor>Peterson MA</RefAuthor> <RefAuthor>Basbaum AI</RefAuthor> <RefTitle>Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine</RefTitle> <RefYear>1997</RefYear> <RefJournal>Pain</RefJournal> <RefPage>101-10</RefPage> <RefTotal>Abbadie C, Taylor BK, Peterson MA, Basbaum AI. Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine. Pain. 1997;69(1-2):101-10.</RefTotal> </Reference> <Reference refNo="4"> <RefAuthor>Catheline G</RefAuthor> <RefAuthor>Le Guen S</RefAuthor> <RefAuthor>Besson JM</RefAuthor> <RefTitle>Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord</RefTitle> <RefYear>1999</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>105-11</RefPage> <RefTotal>Catheline G, Le Guen S, Besson JM. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord. Brain Res. 1999;824(1):105-11.</RefTotal> </Reference> <Reference refNo="5"> <RefAuthor>Ebersberger A</RefAuthor> <RefAuthor>Anton F</RefAuthor> <RefAuthor>Tolle TR</RefAuthor> <RefAuthor>Zieglg&#228;nsberger W</RefAuthor> <RefTitle>Morphine, 5-HT2 and 5-HT3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa</RefTitle> <RefYear>1995</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>336-42</RefPage> <RefTotal>Ebersberger A, Anton F, Tolle TR, Zieglg&#228;nsberger W. Morphine, 5-HT2 and 5-HT3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa. Brain Res. 1995;676(2):336-42.</RefTotal> </Reference> <Reference refNo="6"> <RefAuthor>Matsumoto N</RefAuthor> <RefAuthor>Kawarada K</RefAuthor> <RefAuthor>Kamata K</RefAuthor> <RefAuthor>Suzuki TA</RefAuthor> <RefTitle>Electrical stimulation of tooth pulp increases the expression of c-fos in the cat supraoptic nucleus but not in the paraventricular nucleus</RefTitle> <RefYear>1993</RefYear> <RefJournal>Life Sci</RefJournal> <RefPage>1235-41</RefPage> <RefTotal>Matsumoto N, Kawarada K, Kamata K, Suzuki TA. Electrical stimulation of tooth pulp increases the expression of c-fos in the cat supraoptic nucleus but not in the paraventricular nucleus. Life Sci. 1993;53(15):1235-41.</RefTotal> </Reference> <Reference refNo="7"> <RefAuthor>Kovelowski CJ</RefAuthor> <RefAuthor>Raffa RB</RefAuthor> <RefAuthor>Porreca F</RefAuthor> <RefTitle>Tramadol and its enantiomers differentially suppress c-fos-like immunoreactivity in rat brain and spinal cord following acute noxious stimulus</RefTitle> <RefYear>1998</RefYear> <RefJournal>Eur J Pain</RefJournal> <RefPage>211-9</RefPage> <RefTotal>Kovelowski CJ, Raffa RB, Porreca F. Tramadol and its enantiomers differentially suppress c-fos-like immunoreactivity in rat brain and spinal cord following acute noxious stimulus. Eur J Pain. 1998;2(3):211-9.</RefTotal> </Reference> <Reference refNo="8"> <RefAuthor>Harris JA</RefAuthor> <RefTitle>Using c-fos as a neural marker of pain</RefTitle> <RefYear>1998</RefYear> <RefJournal>Brain Res Bull</RefJournal> <RefPage>1-8</RefPage> <RefTotal>Harris JA. Using c-fos as a neural marker of pain. Brain Res Bull. 1998;45(1):1-8.</RefTotal> </Reference> <Reference refNo="9"> <RefAuthor>Rittner HL</RefAuthor> <RefAuthor>Stein C</RefAuthor> <RefTitle>Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia</RefTitle> <RefYear>2005</RefYear> <RefJournal>Eur J Pain</RefJournal> <RefPage>109-12</RefPage> <RefTotal>Rittner HL, Stein C. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia. Eur J Pain. 2005;9(2):109-12.</RefTotal> </Reference> <Reference refNo="10"> <RefAuthor>Choe H</RefAuthor> <RefAuthor>Choi YS</RefAuthor> <RefAuthor>Kim YH</RefAuthor> <RefAuthor>Ko SH</RefAuthor> <RefAuthor>Choi HG</RefAuthor> <RefAuthor>Han YJ</RefAuthor> <RefAuthor>Song HS</RefAuthor> <RefTitle>Epidural morphine plus ketamine for upper abdominal surgery: improved analgesia from preincisional versus postincisional administration</RefTitle> <RefYear>1997</RefYear> <RefJournal>Anesth Analg</RefJournal> <RefPage>560-3</RefPage> <RefTotal>Choe H, Choi YS, Kim YH, Ko SH, Choi HG, Han YJ, Song HS. Epidural morphine plus ketamine for upper abdominal surgery: improved analgesia from preincisional versus postincisional administration. Anesth Analg. 1997;84(3):560-3.</RefTotal> </Reference> <Reference refNo="11"> <RefAuthor>Aida S</RefAuthor> <RefAuthor>Yamakura T</RefAuthor> <RefAuthor>Baba H</RefAuthor> <RefAuthor>Taga K</RefAuthor> <RefAuthor>Fukuda S</RefAuthor> <RefAuthor>Shimoji K</RefAuthor> <RefTitle>Preemptive analgesia by intravenous low-dose ketamine and epidural morphine in gastrectomy: a randomized double-blind study</RefTitle> <RefYear>2000</RefYear> <RefJournal>Anesthesiology</RefJournal> <RefPage>1624-30</RefPage> <RefTotal>Aida S, Yamakura T, Baba H, Taga K, Fukuda S, Shimoji K. Preemptive analgesia by intravenous low-dose ketamine and epidural morphine in gastrectomy: a randomized double-blind study. Anesthesiology. 2000;92(6):1624-30.</RefTotal> </Reference> <Reference refNo="12"> <RefAuthor>Sun WZ</RefAuthor> <RefAuthor>Shyu BC</RefAuthor> <RefAuthor>Shieh JY</RefAuthor> <RefTitle>Nitrous oxide or halothane, or both, fail to suppress c-fos expression in rat spinal cord dorsal horn neurones after subcutaneous formalin</RefTitle> <RefYear>1996</RefYear> <RefJournal>Br J Anaesth</RefJournal> <RefPage>99-105</RefPage> <RefTotal>Sun WZ, Shyu BC, Shieh JY. Nitrous oxide or halothane, or both, fail to suppress c-fos expression in rat spinal cord dorsal horn neurones after subcutaneous formalin. Br J Anaesth. 1996;76(1):99-105.</RefTotal> </Reference> <Reference refNo="13"> <RefAuthor>Zhang SP</RefAuthor> <RefAuthor>Zhang JS</RefAuthor> <RefAuthor>Yung KK</RefAuthor> <RefAuthor>Zhang HQ</RefAuthor> <RefTitle>Non-opioid-dependent anti-inflammatory effects of low frequency electroacupuncture</RefTitle> <RefYear>2004</RefYear> <RefJournal>Brain Res Bull</RefJournal> <RefPage>327-34</RefPage> <RefTotal>Zhang SP, Zhang JS, Yung KK, Zhang HQ. Non-opioid-dependent anti-inflammatory effects of low frequency electroacupuncture. Brain Res Bull. 2004;62(4):327-34.</RefTotal> </Reference> <Reference refNo="14"> <RefAuthor>Lee IO</RefAuthor> <RefAuthor>Lee IH</RefAuthor> <RefAuthor>Lee KC</RefAuthor> <RefTitle>Pre-versus post-formalin effects of intrathecal ketamine on spinal Fos-like immunoreactivity in rats</RefTitle> <RefYear>2004</RefYear> <RefJournal>Indian J Med Res</RefJournal> <RefPage>527-33</RefPage> <RefTotal>Lee IO, Lee IH, Lee KC. Pre-versus post-formalin effects of intrathecal ketamine on spinal Fos-like immunoreactivity in rats. Indian J Med Res. 2004;120(6):527-33.</RefTotal> </Reference> <Reference refNo="15"> <RefAuthor>Koizuka S</RefAuthor> <RefAuthor>Obata H</RefAuthor> <RefAuthor>Sasaki M</RefAuthor> <RefAuthor>Saito S</RefAuthor> <RefAuthor>Goto F</RefAuthor> <RefTitle>Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats</RefTitle> <RefYear>2005</RefYear> <RefJournal>Can J Anaesth</RefJournal> <RefPage>498-505</RefPage> <RefTotal>Koizuka S, Obata H, Sasaki M, Saito S, Goto F. Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats. Can J Anaesth. 2005;52(5):498-505.</RefTotal> </Reference> <Reference refNo="16"> <RefAuthor>Gilron I</RefAuthor> <RefAuthor>Coderre TJ</RefAuthor> <RefTitle>Novel targets of pain modulation in anaesthesia: preventing painful memories</RefTitle> <RefYear>1997</RefYear> <RefJournal>Can J Anaesth</RefJournal> <RefPage>457-62</RefPage> <RefTotal>Gilron I, Coderre TJ. Novel targets of pain modulation in anaesthesia: preventing painful memories. Can J Anaesth. 1997;44(5 Pt 1):457-62.</RefTotal> </Reference> <Reference refNo="17"> <RefAuthor>Graven-Nielsen T</RefAuthor> <RefAuthor>Aspegren Kendall S</RefAuthor> <RefAuthor>Henriksson KG</RefAuthor> <RefAuthor>Bengtsson M</RefAuthor> <RefAuthor>S&#246;rensen J</RefAuthor> <RefAuthor>Johnson A</RefAuthor> <RefAuthor>Gerdle B</RefAuthor> <RefAuthor>Arendt-Nielsen L</RefAuthor> <RefTitle>Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients</RefTitle> <RefYear>2000</RefYear> <RefJournal>Pain</RefJournal> <RefPage>483-91</RefPage> <RefTotal>Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, S&#246;rensen J, Johnson A, Gerdle B, Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 2000;85(3):483-91.</RefTotal> </Reference> <Reference refNo="18"> <RefAuthor>Warncke T</RefAuthor> <RefAuthor>Stubhaug A</RefAuthor> <RefAuthor>J&#248;rum E</RefAuthor> <RefTitle>Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man</RefTitle> <RefYear>2000</RefYear> <RefJournal>Pain</RefJournal> <RefPage>293-303</RefPage> <RefTotal>Warncke T, Stubhaug A, J&#248;rum E. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man. Pain. 2000;86(3):293-303.</RefTotal> </Reference> <Reference refNo="19"> <RefAuthor>Jaksch W</RefAuthor> <RefAuthor>Lang S</RefAuthor> <RefAuthor>Reichhalter R</RefAuthor> <RefAuthor>Raab G</RefAuthor> <RefAuthor>Dann K</RefAuthor> <RefAuthor>Fitzal S</RefAuthor> <RefTitle>Perioperative small-dose S(&#43;)-ketamine has no incremental beneficial effects on postoperative pain when standard-practice opioid infusions are used</RefTitle> <RefYear>2002</RefYear> <RefJournal>Anesth Analg</RefJournal> <RefPage>981-6</RefPage> <RefTotal>Jaksch W, Lang S, Reichhalter R, Raab G, Dann K, Fitzal S. Perioperative small-dose S(&#43;)-ketamine has no incremental beneficial effects on postoperative pain when standard-practice opioid infusions are used. Anesth Analg. 2002;94(4):981-6.</RefTotal> </Reference> <Reference refNo="20"> <RefAuthor>Fu ES</RefAuthor> <RefAuthor>Miguel R</RefAuthor> <RefAuthor>Scharf JE</RefAuthor> <RefTitle>Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery</RefTitle> <RefYear>1997</RefYear> <RefJournal>Anesth Analg</RefJournal> <RefPage>1086-90</RefPage> <RefTotal>Fu ES, Miguel R, Scharf JE. Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery. Anesth Analg. 1997;84(5):1086-90.</RefTotal> </Reference> <Reference refNo="21"> <RefAuthor>Kucuk N</RefAuthor> <RefAuthor>Kizilkaya M</RefAuthor> <RefAuthor>Tokdemir M</RefAuthor> <RefTitle>Preoperative epidural ketamine does not have a postoperative opioid sparing effect</RefTitle> <RefYear>1998</RefYear> <RefJournal>Anesth Analg</RefJournal> <RefPage>103-6</RefPage> <RefTotal>Kucuk N, Kizilkaya M, Tokdemir M. Preoperative epidural ketamine does not have a postoperative opioid sparing effect. Anesth Analg. 1998;87(1):103-6.</RefTotal> </Reference> <Reference refNo="22"> <RefAuthor>Zou CJ</RefAuthor> <RefAuthor>Liu JD</RefAuthor> <RefAuthor>Zhou YC</RefAuthor> <RefTitle>Roles of central interleukin-1 on stress-induced-hypertension and footshock-induced-analgesia in rats</RefTitle> <RefYear>2001</RefYear> <RefJournal>Neurosci Lett</RefJournal> <RefPage>41-4</RefPage> <RefTotal>Zou CJ, Liu JD, Zhou YC. Roles of central interleukin-1 on stress-induced-hypertension and footshock-induced-analgesia in rats. Neurosci Lett. 2001;311(1):41-4.</RefTotal> </Reference> <Reference refNo="23"> <RefAuthor>Vendruscolo LF</RefAuthor> <RefAuthor>Pamplona FA</RefAuthor> <RefAuthor>Takahashi RN</RefAuthor> <RefTitle>Strain and sex differences in the expression of nociceptive behavior and stress-induced analgesia in rats</RefTitle> <RefYear>2004</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>277-83</RefPage> <RefTotal>Vendruscolo LF, Pamplona FA, Takahashi RN. Strain and sex differences in the expression of nociceptive behavior and stress-induced analgesia in rats. Brain Res. 2004;1030(2):277-83.</RefTotal> </Reference> <Reference refNo="24"> <RefAuthor>Costa A</RefAuthor> <RefAuthor>Smeraldi A</RefAuthor> <RefAuthor>Tassorelli C</RefAuthor> <RefAuthor>Greco R</RefAuthor> <RefAuthor>Nappi G</RefAuthor> <RefTitle>Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats</RefTitle> <RefYear>2005</RefYear> <RefJournal>Neurosci Lett</RefJournal> <RefPage>7-11</RefPage> <RefTotal>Costa A, Smeraldi A, Tassorelli C, Greco R, Nappi G. Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats. Neurosci Lett. 2005;383(1-2):7-11.</RefTotal> </Reference> <Reference refNo="25"> <RefAuthor>Amit Z</RefAuthor> <RefAuthor>Galina ZH</RefAuthor> <RefTitle>Stress-induced analgesia: adaptive pain suppression</RefTitle> <RefYear>1986</RefYear> <RefJournal>Physiol Rev</RefJournal> <RefPage>1091-120</RefPage> <RefTotal>Amit Z, Galina ZH. Stress-induced analgesia: adaptive pain suppression. Physiol Rev. 1986;66(4):1091-120.</RefTotal> </Reference> <Reference refNo="26"> <RefAuthor>Grau JW</RefAuthor> <RefTitle>The central representation of an aversive event maintains the opioid and nonopioid forms of analgesia</RefTitle> <RefYear>1987</RefYear> <RefJournal>Behav Neurosci</RefJournal> <RefPage>272-88</RefPage> <RefTotal>Grau JW. The central representation of an aversive event maintains the opioid and nonopioid forms of analgesia. Behav Neurosci. 1987;101(2):272-88.</RefTotal> </Reference> <Reference refNo="27"> <RefAuthor>Herbert J</RefAuthor> <RefTitle>Fortnighly review. Stress, the brain, and mental illness</RefTitle> <RefYear>1997</RefYear> <RefJournal>BMJ</RefJournal> <RefPage>530-5</RefPage> <RefTotal>Herbert J. Fortnighly review. Stress, the brain, and mental illness. BMJ. 1997;315(7107):530-5.</RefTotal> </Reference> <Reference refNo="28"> <RefAuthor>Ueyama T</RefAuthor> <RefAuthor>Saika M</RefAuthor> <RefAuthor>Koreeda C</RefAuthor> <RefAuthor>Senba E</RefAuthor> <RefTitle>Water immersion-restraint stress induces expression of immediate-early genes in gastrointestinal tract of rats</RefTitle> <RefYear>1998</RefYear> <RefJournal>Am J Physiol</RefJournal> <RefPage>G287-95</RefPage> <RefTotal>Ueyama T, Saika M, Koreeda C, Senba E. Water immersion-restraint stress induces expression of immediate-early genes in gastrointestinal tract of rats. Am J Physiol. 1998;275(2 Pt 1):G287-95.</RefTotal> </Reference> <Reference refNo="29"> <RefAuthor>Dickenson AH</RefAuthor> <RefAuthor>Chapman V</RefAuthor> <RefAuthor>Green GM</RefAuthor> <RefTitle>The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord</RefTitle> <RefYear>1997</RefYear> <RefJournal>Gen Pharmacol</RefJournal> <RefPage>633-8</RefPage> <RefTotal>Dickenson AH, Chapman V, Green GM. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol. 1997;28(5):633-8.</RefTotal> </Reference> <Reference refNo="30"> <RefAuthor>Harris JA</RefAuthor> <RefAuthor>Westbrook RF</RefAuthor> <RefAuthor>Duffield TQ</RefAuthor> <RefAuthor>Bentivoglio M</RefAuthor> <RefTitle>Fos expression in the spinal cord is suppressed in rats displaying conditioned hypoalgesia</RefTitle> <RefYear>1995</RefYear> <RefJournal>Behav Neurosci</RefJournal> <RefPage>320-8</RefPage> <RefTotal>Harris JA, Westbrook RF, Duffield TQ, Bentivoglio M. Fos expression in the spinal cord is suppressed in rats displaying conditioned hypoalgesia. Behav Neurosci. 1995;109(2):320-8.</RefTotal> </Reference> <Reference refNo="31"> <RefAuthor>Dubuisson D</RefAuthor> <RefAuthor>Dennis SG</RefAuthor> <RefTitle>The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</RefTitle> <RefYear>1977</RefYear> <RefJournal>Pain</RefJournal> <RefPage>161-74</RefPage> <RefTotal>Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4(2):161-74.</RefTotal> </Reference> <Reference refNo="32"> <RefAuthor>Vanderah TW</RefAuthor> <RefAuthor>Wild KD</RefAuthor> <RefAuthor>Takemori AE</RefAuthor> <RefAuthor>Sultana M</RefAuthor> <RefAuthor>Portoghese PS</RefAuthor> <RefAuthor>Bowen WD</RefAuthor> <RefAuthor>Mosberg HI</RefAuthor> <RefAuthor>Porreca F</RefAuthor> <RefTitle>Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse</RefTitle> <RefYear>1992</RefYear> <RefJournal>J Pharmacol Exp Ther</RefJournal> <RefPage>190-7</RefPage> <RefTotal>Vanderah TW, Wild KD, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F. Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse. J Pharmacol Exp Ther. 1992;262(1):190-7.</RefTotal> </Reference> <Reference refNo="33"> <RefAuthor>Vaccarino AL</RefAuthor> <RefAuthor>Marek P</RefAuthor> <RefAuthor>Liebeskind JC</RefAuthor> <RefTitle>Stress-induced analgesia prevents the development of the tonic, late phase of pain produced by subcutaneous formalin</RefTitle> <RefYear>1992</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>250-2</RefPage> <RefTotal>Vaccarino AL, Marek P, Liebeskind JC. Stress-induced analgesia prevents the development of the tonic, late phase of pain produced by subcutaneous formalin. Brain Res. 1992;572(1-2):250-2.</RefTotal> </Reference> <Reference refNo="34"> <RefAuthor>Gogas KR</RefAuthor> <RefAuthor>Cho HJ</RefAuthor> <RefAuthor>Botchkina GI</RefAuthor> <RefAuthor>Levine JD</RefAuthor> <RefAuthor>Basbaum AI</RefAuthor> <RefTitle>Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine</RefTitle> <RefYear>1996</RefYear> <RefJournal>Pain</RefJournal> <RefPage>9-15</RefPage> <RefTotal>Gogas KR, Cho HJ, Botchkina GI, Levine JD, Basbaum AI. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain. 1996;65(1):9-15.</RefTotal> </Reference> <Reference refNo="35"> <RefAuthor>Sawamura S</RefAuthor> <RefAuthor>Fujinaga M</RefAuthor> <RefAuthor>Kingery WS</RefAuthor> <RefAuthor>Belanger N</RefAuthor> <RefAuthor>Davies MF</RefAuthor> <RefAuthor>Maze M</RefAuthor> <RefTitle>Opioidergic and adrenergic modulation of formalin-evoked spinal c-fos mRNA expression and nocifensive behavior in the rat</RefTitle> <RefYear>1999</RefYear> <RefJournal>Eur J Pharmacol</RefJournal> <RefPage>141-9</RefPage> <RefTotal>Sawamura S, Fujinaga M, Kingery WS, Belanger N, Davies MF, Maze M. Opioidergic and adrenergic modulation of formalin-evoked spinal c-fos mRNA expression and nocifensive behavior in the rat. Eur J Pharmacol. 1999;379(2-3):141-9.</RefTotal> </Reference> <Reference refNo="36"> <RefAuthor>Hao S</RefAuthor> <RefAuthor>Takahata O</RefAuthor> <RefAuthor>Mamiya K</RefAuthor> <RefAuthor>Iwasaki H</RefAuthor> <RefTitle>Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems</RefTitle> <RefYear>2002</RefYear> <RefJournal>Life Sci</RefJournal> <RefPage>571-80</RefPage> <RefTotal>Hao S, Takahata O, Mamiya K, Iwasaki H. Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems. Life Sci. 2002;71(5):571-80.</RefTotal> </Reference> <Reference refNo="37"> <RefAuthor>Gilron I</RefAuthor> <RefAuthor>Quirion R</RefAuthor> <RefAuthor>Coderre TJ</RefAuthor> <RefTitle>Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity</RefTitle> <RefYear>1999</RefYear> <RefJournal>Anesth Analg</RefJournal> <RefPage>128-35</RefPage> <RefTotal>Gilron I, Quirion R, Coderre TJ. Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity. Anesth Analg. 1999;89(1):128-35.</RefTotal> </Reference> <Reference refNo="38"> <RefAuthor>Jennings E</RefAuthor> <RefAuthor>Fitzgerald M</RefAuthor> <RefTitle>C-fos can be induced in the neonatal rat spinal cord by both noxious and innocuous peripheral stimulation</RefTitle> <RefYear>1996</RefYear> <RefJournal>Pain</RefJournal> <RefPage>301-6</RefPage> <RefTotal>Jennings E, Fitzgerald M. C-fos can be induced in the neonatal rat spinal cord by both noxious and innocuous peripheral stimulation. Pain. 1996;68(2-3):301-6.</RefTotal> </Reference> <Reference refNo="39"> <RefAuthor>Ji RR</RefAuthor> <RefAuthor>Rupp F</RefAuthor> <RefTitle>Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction</RefTitle> <RefYear>1997</RefYear> <RefJournal>J Neurosci</RefJournal> <RefPage>1776-85</RefPage> <RefTotal>Ji RR, Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J Neurosci. 1997;17(5):1776-85.</RefTotal> </Reference> <Reference refNo="40"> <RefAuthor>Huang W</RefAuthor> <RefAuthor>Simpson RK Jr</RefAuthor> <RefTitle>Ketamine suppresses c-fos expression in dorsal horn neurons after acute constrictive sciatic nerve injury in the rat</RefTitle> <RefYear>1999</RefYear> <RefJournal>Neurosci Lett</RefJournal> <RefPage>165-8</RefPage> <RefTotal>Huang W, Simpson RK Jr. Ketamine suppresses c-fos expression in dorsal horn neurons after acute constrictive sciatic nerve injury in the rat. Neurosci Lett. 1999;269(3):165-8.</RefTotal> </Reference> <Reference refNo="41"> <RefAuthor>Bontempi B</RefAuthor> <RefAuthor>Sharp FR</RefAuthor> <RefTitle>Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area</RefTitle> <RefYear>1997</RefYear> <RefJournal>J Neurosci</RefJournal> <RefPage>8596-612</RefPage> <RefTotal>Bontempi B, Sharp FR. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J Neurosci. 1997;17(21):8596-612.</RefTotal> </Reference> <Reference refNo="42"> <RefAuthor>Molander C</RefAuthor> <RefAuthor>Xu Q</RefAuthor> <RefAuthor>Grant G</RefAuthor> <RefTitle>The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord</RefTitle> <RefYear>1984</RefYear> <RefJournal>J Comp Neurol</RefJournal> <RefPage>133-41</RefPage> <RefTotal>Molander C, Xu Q, Grant G. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol. 1984;230(1):133-41.</RefTotal> </Reference> <Reference refNo="43"> <RefAuthor>Nakao S</RefAuthor> <RefAuthor>Miyamoto E</RefAuthor> <RefAuthor>Masuzawa M</RefAuthor> <RefAuthor>Kambara T</RefAuthor> <RefAuthor>Shingu K</RefAuthor> <RefTitle>Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors</RefTitle> <RefYear>2002</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>191-6</RefPage> <RefTotal>Nakao S, Miyamoto E, Masuzawa M, Kambara T, Shingu K. Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res. 2002;926(1-2):191-6.</RefTotal> </Reference> <Reference refNo="44"> <RefAuthor>Shibata M</RefAuthor> <RefAuthor>Ohkubo T</RefAuthor> <RefAuthor>Takahashi H</RefAuthor> <RefAuthor>Inoki R</RefAuthor> <RefTitle>Modified formalin test: characteristic biphasic pain response</RefTitle> <RefYear>1989</RefYear> <RefJournal>Pain</RefJournal> <RefPage>347-52</RefPage> <RefTotal>Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 1989;38: 347-52.</RefTotal> </Reference> <Reference refNo="45"> <RefAuthor>Tj&#248;lsen A</RefAuthor> <RefAuthor>Berge OG</RefAuthor> <RefAuthor>Hunskaar S</RefAuthor> <RefAuthor>Rosland JH</RefAuthor> <RefAuthor>Hole K</RefAuthor> <RefTitle>The formalin test: an evaluation of the method</RefTitle> <RefYear>1992</RefYear> <RefJournal>Pain</RefJournal> <RefPage>5-17</RefPage> <RefTotal>Tj&#248;lsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5-17.</RefTotal> </Reference> <Reference refNo="46"> <RefAuthor>Sawynok J</RefAuthor> <RefAuthor>Reid A</RefAuthor> <RefTitle>Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine</RefTitle> <RefYear>2002</RefYear> <RefJournal>Eur J Pharmacol</RefJournal> <RefPage>153-62</RefPage> <RefTotal>Sawynok J, Reid A. Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine. Eur J Pharmacol. 2002;450(2):153-62.</RefTotal> </Reference> <Reference refNo="47"> <RefAuthor>Lee IO</RefAuthor> <RefAuthor>Lee IH</RefAuthor> <RefTitle>Systemic, but not Intrathecal, Ketamine Produces Preemptive Analgesia in the Rat Formalin Model</RefTitle> <RefYear>2001</RefYear> <RefJournal>Acta Anaesthesiol Sin</RefJournal> <RefPage>123-7</RefPage> <RefTotal>Lee IO, Lee IH. Systemic, but not Intrathecal, Ketamine Produces Preemptive Analgesia in the Rat Formalin Model. Acta Anaesthesiol Sin. 2001;39(3):123-7.</RefTotal> </Reference> <Reference refNo="48"> <RefAuthor>Yamamoto T</RefAuthor> <RefAuthor>Yaksh TL</RefAuthor> <RefTitle>Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat</RefTitle> <RefYear>1992</RefYear> <RefJournal>Anesthesiology</RefJournal> <RefPage>757-63</RefPage> <RefTotal>Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 1992;77(4):757-63.</RefTotal> </Reference> <Reference refNo="49"> <RefAuthor>Annetta MG</RefAuthor> <RefAuthor>Iemma D</RefAuthor> <RefAuthor>Garisto C</RefAuthor> <RefAuthor>Tafani C</RefAuthor> <RefAuthor>Proietti R</RefAuthor> <RefTitle>Ketamine: new indications for an old drug</RefTitle> <RefYear>2005</RefYear> <RefJournal>Curr Drug Targets</RefJournal> <RefPage>789-94</RefPage> <RefTotal>Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R. Ketamine: new indications for an old drug. Curr Drug Targets. 2005;6(7): 789-94.</RefTotal> </Reference> <Reference refNo="50"> <RefAuthor>Hao JX</RefAuthor> <RefAuthor>Sj&#246;lund BH</RefAuthor> <RefAuthor>Wiesenfeld-Hallin Z</RefAuthor> <RefTitle>Electrophysiological evidence for an antinociceptive effect of ketamine in the rat spinal cord</RefTitle> <RefYear>1998</RefYear> <RefJournal>Acta Anaesthesiol Scand</RefJournal> <RefPage>435-41</RefPage> <RefTotal>Hao JX, Sj&#246;lund BH, Wiesenfeld-Hallin Z. Electrophysiological evidence for an antinociceptive effect of ketamine in the rat spinal cord. Acta Anaesthesiol Scand. 1998;42(4):435-41.</RefTotal> </Reference> <Reference refNo="51"> <RefAuthor>Chaplan SR</RefAuthor> <RefAuthor>Malmberg AB</RefAuthor> <RefAuthor>Yaksh TL</RefAuthor> <RefTitle>Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat</RefTitle> <RefYear>1997</RefYear> <RefJournal>J Pharmacol Exp Ther</RefJournal> <RefPage>829-38</RefPage> <RefTotal>Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther. 1997;280:829-38.</RefTotal> </Reference> <Reference refNo="52"> <RefAuthor>Kawamata T</RefAuthor> <RefAuthor>Omote K</RefAuthor> <RefAuthor>Sonoda H</RefAuthor> <RefAuthor>Kawamata M</RefAuthor> <RefAuthor>Namiki A</RefAuthor> <RefTitle>Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation</RefTitle> <RefYear>2000</RefYear> <RefJournal>Anesthesiology</RefJournal> <RefPage>520-8</RefPage> <RefTotal>Kawamata T, Omote K, Sonoda H, Kawamata M, Namiki A. Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology. 2000;93(2): 520-8.</RefTotal> </Reference> <Reference refNo="53"> <RefAuthor>Shimoyama M</RefAuthor> <RefAuthor>Shimoyama N</RefAuthor> <RefAuthor>Gorman AL</RefAuthor> <RefAuthor>Elliott KJ</RefAuthor> <RefAuthor>Inturrisi CE</RefAuthor> <RefTitle>Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine</RefTitle> <RefYear>1999</RefYear> <RefJournal>Pain</RefJournal> <RefPage>85-93</RefPage> <RefTotal>Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain. 1999;81(1-2):85-93.</RefTotal> </Reference> <Reference refNo="54"> <RefAuthor>Sevostianova N</RefAuthor> <RefAuthor>Danysz W</RefAuthor> <RefAuthor>Bespalov AY</RefAuthor> <RefTitle>Analgesic effects of morphine and loperamide in the rat formalin test: Interactions with NMDA receptor antagonists</RefTitle> <RefYear>2005</RefYear> <RefJournal>Eur J Pharmacol</RefJournal> <RefPage>83-90</RefPage> <RefTotal>Sevostianova N, Danysz W, Bespalov AY. Analgesic effects of morphine and loperamide in the rat formalin test: Interactions with NMDA receptor antagonists. Eur J Pharmacol. 2005;525(1-3):83-90.</RefTotal> </Reference> <Reference refNo="55"> <RefAuthor>Benrath J</RefAuthor> <RefAuthor>Brechtel C</RefAuthor> <RefAuthor>Stark J</RefAuthor> <RefAuthor>Sandk&#252;hler J</RefAuthor> <RefTitle>Low dose of S&#43;-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo</RefTitle> <RefYear>2005</RefYear> <RefJournal>Br J Anaesth</RefJournal> <RefPage>518-23</RefPage> <RefTotal>Benrath J, Brechtel C, Stark J, Sandk&#252;hler J. Low dose of S&#43;-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. Br J Anaesth. 2005;95(4):518-23.</RefTotal> </Reference> <Reference refNo="56"> <RefAuthor>Kamei J</RefAuthor> <RefAuthor>Hitosugi H</RefAuthor> <RefAuthor>Misawa M</RefAuthor> <RefAuthor>Nagase H</RefAuthor> <RefAuthor>Kasuya Y</RefAuthor> <RefTitle>Delta-Opioid receptor-mediated forced swimming stress-induced antinociception in the formalin test</RefTitle> <RefYear>1993</RefYear> <RefJournal>Psychopharmacology (Berl.)</RefJournal> <RefPage>15-8</RefPage> <RefTotal>Kamei J, Hitosugi H, Misawa M, Nagase H, Kasuya Y. Delta-Opioid receptor-mediated forced swimming stress-induced antinociception in the formalin test. Psychopharmacology (Berl.). 1993;113(1):15-8.</RefTotal> </Reference> <Reference refNo="57"> <RefAuthor>Deutsch SI</RefAuthor> <RefAuthor>Mastropaolo J</RefAuthor> <RefAuthor>Riggs RL</RefAuthor> <RefAuthor>Rosse RB</RefAuthor> <RefTitle>The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress</RefTitle> <RefYear>1997</RefYear> <RefJournal>Pharmacol Biochem Behav</RefJournal> <RefPage>709-12</RefPage> <RefTotal>Deutsch SI, Mastropaolo J, Riggs RL, Rosse RB. The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress. Pharmacol Biochem Behav. 1997;58(3):709-12.</RefTotal> </Reference> <Reference refNo="58"> <RefAuthor>Tateyama S</RefAuthor> <RefAuthor>Ikeda T</RefAuthor> <RefAuthor>Kosai K</RefAuthor> <RefAuthor>Nakamura T</RefAuthor> <RefAuthor>Kasaba T</RefAuthor> <RefAuthor>Takasaki M</RefAuthor> <RefAuthor>Nishimori T</RefAuthor> <RefTitle>Endomorphins suppress nociception-induced c-Fos and Zif&#47;268 expression in the rat spinal dorsal horn</RefTitle> <RefYear>2002</RefYear> <RefJournal>Eur J Pharmacol</RefJournal> <RefPage>79-87</RefPage> <RefTotal>Tateyama S, Ikeda T, Kosai K, Nakamura T, Kasaba T, Takasaki M, Nishimori T. Endomorphins suppress nociception-induced c-Fos and Zif&#47;268 expression in the rat spinal dorsal horn. Eur J Pharmacol. 2002;451(1):79-87.</RefTotal> </Reference> <Reference refNo="59"> <RefAuthor>Labuz D</RefAuthor> <RefAuthor>Chocyk A</RefAuthor> <RefAuthor>Wedzony K</RefAuthor> <RefAuthor>Toth G</RefAuthor> <RefAuthor>Przewlocka B</RefAuthor> <RefTitle>Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord</RefTitle> <RefYear>2003</RefYear> <RefJournal>Life Sci</RefJournal> <RefPage>403-12</RefPage> <RefTotal>Labuz D, Chocyk A, Wedzony K, Toth G, Przewlocka B. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Life Sci. 2003;73(4):403-12.</RefTotal> </Reference> <Reference refNo="60"> <RefAuthor>Abbadie C</RefAuthor> <RefAuthor>Besson JM</RefAuthor> <RefTitle>C-fos expression in rat lumbar spinal cord following peripheral stimulation in adjuvant-induced arthritic and normal rats</RefTitle> <RefYear>1993</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>195-204</RefPage> <RefTotal>Abbadie C, Besson JM. C-fos expression in rat lumbar spinal cord following peripheral stimulation in adjuvant-induced arthritic and normal rats. Brain Res. 1993;607(1-2):195-204.</RefTotal> </Reference> <Reference refNo="61"> <RefAuthor>Liu RJ</RefAuthor> <RefAuthor>Qiang M</RefAuthor> <RefAuthor>Qiao JT</RefAuthor> <RefTitle>Nociceptive c-fos expression in supraspinal areas in avoidance of descending suppression at the spinal relay station</RefTitle> <RefYear>1998</RefYear> <RefJournal>Neuroscience</RefJournal> <RefPage>1073-1087</RefPage> <RefTotal>Liu RJ, Qiang M, Qiao JT. Nociceptive c-fos expression in supraspinal areas in avoidance of descending suppression at the spinal relay station. Neuroscience. 1998;85(4):1073-1087.</RefTotal> </Reference> <Reference refNo="62"> <RefAuthor>Kosek E</RefAuthor> <RefAuthor>Lundberg L</RefAuthor> <RefTitle>Segmental and plurisegmental modulation of pressure pain thresholds during static muscle contractions in healthy individuals</RefTitle> <RefYear>2003</RefYear> <RefJournal>Eur J Pain</RefJournal> <RefPage>251-8</RefPage> <RefTotal>Kosek E, Lundberg L. Segmental and plurisegmental modulation of pressure pain thresholds during static muscle contractions in healthy individuals. Eur J Pain. 2003;7(3):251-8.</RefTotal> </Reference> <Reference refNo="63"> <RefAuthor>Woda A</RefAuthor> <RefAuthor>Blanc O</RefAuthor> <RefAuthor>Voisin DL</RefAuthor> <RefAuthor>Coste J</RefAuthor> <RefAuthor>Molat JL</RefAuthor> <RefAuthor>Luccarini P</RefAuthor> <RefTitle>Bidirectional modulation of windup by NMDA receptors in the rat spinal trigeminal nucleus</RefTitle> <RefYear>2004</RefYear> <RefJournal>Eur J Neurosci</RefJournal> <RefPage>2009-16</RefPage> <RefTotal>Woda A, Blanc O, Voisin DL, Coste J, Molat JL, Luccarini P. Bidirectional modulation of windup by NMDA receptors in the rat spinal trigeminal nucleus. Eur J Neurosci. 2004;19(8):2009-16.</RefTotal> </Reference> <Reference refNo="64"> <RefAuthor>Bruijnzeel AW</RefAuthor> <RefAuthor>Stam R</RefAuthor> <RefAuthor>Compaan JC</RefAuthor> <RefAuthor>Croiset G</RefAuthor> <RefAuthor>Akkermans LM</RefAuthor> <RefAuthor>Olivier B</RefAuthor> <RefAuthor>Wiegant VM</RefAuthor> <RefTitle>Long-term sensitization of Fos-responsivity in the rat central nervous system after a single stressful experience</RefTitle> <RefYear>1999</RefYear> <RefJournal>Brain Res</RefJournal> <RefPage>15-22</RefPage> <RefTotal>Bruijnzeel AW, Stam R, Compaan JC, Croiset G, Akkermans LM, Olivier B, Wiegant VM. Long-term sensitization of Fos-responsivity in the rat central nervous system after a single stressful experience. Brain Res. 1999;819(1-2):15-22.</RefTotal> </Reference> <Reference refNo="65"> <RefAuthor>de Lange RP</RefAuthor> <RefAuthor>Geerse GJ</RefAuthor> <RefAuthor>Dahlhaus M</RefAuthor> <RefAuthor>van Laar TJ</RefAuthor> <RefAuthor>Wiegant VM</RefAuthor> <RefAuthor>Stam R</RefAuthor> <RefTitle>Altered brain stem responsivity to duodenal pain after a single stressful experience</RefTitle> <RefYear>2005</RefYear> <RefJournal>Neurosci Lett</RefJournal> <RefPage>144-8</RefPage> <RefTotal>de Lange RP, Geerse GJ, Dahlhaus M,van Laar TJ, Wiegant VM, Stam R. Altered brain stem responsivity to duodenal pain after a single stressful experience. Neurosci Lett. 2005;381(1-2):144-8.</RefTotal> </Reference> <Reference refNo="66"> <RefAuthor>Crane JW</RefAuthor> <RefAuthor>French KR</RefAuthor> <RefAuthor>Buller KM</RefAuthor> <RefTitle>Patterns of neuronal activation in the rat brain and spinal cord in response to increasing durations of restraint stress</RefTitle> <RefYear>2005</RefYear> <RefJournal>Stress</RefJournal> <RefPage>199-211</RefPage> <RefTotal>Crane JW, French KR, Buller KM. Patterns of neuronal activation in the rat brain and spinal cord in response to increasing durations of restraint stress. Stress. 2005;8(3):199-211.</RefTotal> </Reference> <Reference refNo="67"> <RefAuthor>Frenkel C</RefAuthor> <RefAuthor>Urban BW</RefAuthor> <RefTitle>Molecular actions of racemic ketamine on human CNS sodium channels</RefTitle> <RefYear>1992</RefYear> <RefJournal>Br J Anaesth</RefJournal> <RefPage>292-7</RefPage> <RefTotal>Frenkel C, Urban BW. Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth. 1992;69(3):292-7.</RefTotal> </Reference> <Reference refNo="68"> <RefAuthor>Castro AR</RefAuthor> <RefAuthor>Pinto M</RefAuthor> <RefAuthor>Lima D</RefAuthor> <RefAuthor>Tavares I</RefAuthor> <RefTitle>Imbalance between the expression of NK1 and GABAB receptors in nociceptive spinal neurons during secondary hyperalgesia: a c-Fos study in the monoarthritic rat</RefTitle> <RefYear>2005</RefYear> <RefJournal>Neuroscience</RefJournal> <RefPage>905-16</RefPage> <RefTotal>Castro AR, Pinto M, Lima D, Tavares I. Imbalance between the expression of NK1 and GABAB receptors in nociceptive spinal neurons during secondary hyperalgesia: a c-Fos study in the monoarthritic rat. Neuroscience. 2005;132(4):905-16.</RefTotal> </Reference> <Reference refNo="69"> <RefAuthor>Herdegen T</RefAuthor> <RefAuthor>Leah JD</RefAuthor> <RefTitle>Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB&#47;ATF proteins</RefTitle> <RefYear>1998</RefYear> <RefJournal>Brain Res Brain Res Rev</RefJournal> <RefPage>370-490</RefPage> <RefTotal>Herdegen T, Leah JD. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB&#47;ATF proteins. Brain Res Brain Res Rev. 1998;28(3):370-490.</RefTotal> </Reference> <Reference refNo="70"> <RefAuthor>Hoffman GE</RefAuthor> <RefAuthor>Lyo D</RefAuthor> <RefTitle>Anatomical markers of activity in neuroendocrine systems: Are we all &#39;fos-ed out&#39;&#63;</RefTitle> <RefYear>2002</RefYear> <RefJournal>J Neuroendocrinol</RefJournal> <RefPage>259-68</RefPage> <RefTotal>Hoffman GE, Lyo D. Anatomical markers of activity in neuroendocrine systems: Are we all &#39;fos-ed out&#39;&#63; J Neuroendocrinol. 2002;14(4):259-68.</RefTotal> </Reference> <Reference refNo="71"> <RefAuthor>De Bruin JT</RefAuthor> <RefAuthor>Sch&#228;fer MK</RefAuthor> <RefAuthor>Krohne HW</RefAuthor> <RefAuthor>Dreyer A</RefAuthor> <RefTitle>Preoperative anxiety, coping, and intraoperative adjustment: Are there mediating effects of stress-induced analgesia&#63;</RefTitle> <RefYear>2001</RefYear> <RefJournal>Psychol Health</RefJournal> <RefPage>253-71</RefPage> <RefTotal>De Bruin JT, Sch&#228;fer MK, Krohne HW, Dreyer A. Preoperative anxiety, coping, and intraoperative adjustment: Are there mediating effects of stress-induced analgesia&#63; Psychol Health. 2001;16(3):253-71.</RefTotal> </Reference> </References> <Media> <Tables> <Table format="png"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption> <Pgraph> <Mark1>Table 1: F values obtained with two-way ANOVA on FLI for stress and non-stress groups and the three drug treatment (ipsilateral side) </Mark1> </Pgraph> </Caption> </Table> <Table format="png"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption> <Pgraph> <Mark1>Table 2: F values obtained with two-way ANOVA on FLI for stress and non-stress groups and the three drug treatment (contralateral side)</Mark1> </Pgraph> </Caption> </Table> <NoOfTables>2</NoOfTables> </Tables> <Figures> <Figure format="png" height="268" width="925"> <MediaNo>3</MediaNo> <MediaID>3</MediaID> <Caption> <Pgraph><Mark1>Figure 3: Photomicrographs showing FLI in spinal cord sections at level L4&#47;L5 of non-stressed groups in different laminae (ipsilateral side). (a) saline; (b) morphine; (c) ketamine. I&#8211;II: superficial lamina; III&#8211;IV: nucleus proprius; V&#8211;VI: neck of dorsal horn. Arrow indicates the dark staining Fos positive neurons (FLI) (</Mark1><Mark1><Mark2>magnification X 50</Mark2></Mark1><Mark1>)</Mark1>.</Pgraph> </Caption> </Figure> <Figure format="png" height="275" width="819"> <MediaNo>4</MediaNo> <MediaID>4</MediaID> <Caption> <Pgraph> <Mark1>Figure 4: Photomicrographs showing FLI in spinal cord sections at level L4&#47;L5 of stressed groups (ipsilateral side). (a) saline; (b) morphine; (c) ketamine. Arrow indicates the dark staining Fos positive neurons (FLI) (</Mark1> <Mark1> <Mark2>magnification X 50</Mark2> </Mark1> <Mark1>).</Mark1> </Pgraph> </Caption> </Figure> <Figure format="png" height="534" width="732"> <MediaNo>5</MediaNo> <MediaID>5</MediaID> <Caption> <Pgraph> <Mark1>Figure 5: Comparison of FLI in (a) saline, (b) morphine, and (c) ketamine stressed and non-stressed groups (ipsilateral side). For comparison between drug groups, please refer to text. n&#61;5 for both goups. Values are means &#177; S.E.M.</Mark1> </Pgraph> </Caption> </Figure> <Figure format="png" height="530" width="731"> <MediaNo>6</MediaNo> <MediaID>6</MediaID> <Caption> <Pgraph> <Mark1>Figure 6: Comparison of FLI in (a) saline, (b) morphine, and (c) ketamine stressed and non-stressed groups (contralateral side). For comparison between drug groups, please refer to text. n&#61;5 for both goups. Values are means &#177; S.E.M.</Mark1> </Pgraph> </Caption> </Figure> <Figure format="png" height="594" width="599"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption> <Pgraph> <Mark1>Figure 2: Mean formalin test scores in stressed groups against time. Values are means &#177; S.E.M. </Mark1> </Pgraph> </Caption> </Figure> <Figure format="png" height="600" width="591"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption> <Pgraph> <Mark1>Figure 1: Mean formalin test scores in non-stressed groups against time. n&#61;8 for all groups. Values are means &#177; S.E.M.</Mark1> </Pgraph> </Caption> </Figure> <NoOfPictures>6</NoOfPictures> </Figures> <InlineFigures> <NoOfPictures>0</NoOfPictures> </InlineFigures> <Attachments> <NoOfAttachments>0</NoOfAttachments> </Attachments> </Media> </OrigData> </GmsArticle>